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During early pregnancy, an orchestrated evolutionary maternal adaption toward tolerance of the semiallogeneic fetus is required
to ensure decidualization and early embryo development. Remodeling of the immune system involves natural killer cells (NKs),
macrophages, T cells and dendritic cells (DCs) altering the microenvironment in the deciduas. In particular, a unique population
of NK cells with a CD56brightCD16− phenotype in the decidua has been proposed to play a key role in the maternal adaptation
to pregnancy. However, there is a tendency for pregnancy immunology to reflect transplantation immunology regarding the
assumption that the maternal immune system should be suppressed. This tendency is misleading. We discuss how the immune
system is formed in early deciduas and the interactions between maternal NK cells and fetal growth. We propose that the maternal
immune response must not be fully suppressed and is even necessary for the local response of uterine NK cells.
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INTRODUCTION
During human pregnancy, extravillous trophoblast cells
(EVT) from the fetus invade the deciduas and remodel the
maternal spiral arteries to ensure adequate nutrition to the
developing fetus. This remodeling of the maternal spiral
arteries is associated with an evolutionary immunological
scenario of maternal adaption toward the semiallogeneic
fetus (Arck and Hecher, 2013; Erlebacher, 2013a; Fu et al.,
2014). Over the past decades of pregnancy research, the ex-
amination of the interactions between the maternal immune
system and fetal trophoblast cells has led to the realization
that multiple mechanisms may be involved in promoting
*Correspondence author (email: fbq@ustc.edu.cn)
immune cell homeostasis during pregnancy.
It has been reported that the TH2-type cytokine profile
(Piccinni et al., 1998; Saito et al., 1999; Mjosberg et al.,
2010), transforming growth factor (TGF)-β1 (Ayatollahi et
al., 2005), altered micro-RNA expression (Bidarimath et
al., 2014), variation within extracellular vesicle populations
(Tannetta et al., 2014) and the inhibition of complement
activation (Xu et al., 2000) are all critical for a successful
pregnancy. CD25+CD4+ regulatory T cells both in mice and
humans have been shown to be very important in the gener-
ation of fetomaternal tolerance. Furthermore, studies have
shown that galectin-1 (Blois et al., 2007) and indoleamine
2,3-dioxygenase (Munn et al., 1998) play pivotal roles in
maternal-fetal tolerance. Wnt, PD-L1, signal transducers,
activators of transcription (STAT) 3 and stimulatory (CD80
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and CD86) signals also participate in the regulation of preg-
nancy (Guleria et al., 2005; Poehlmann et al., 2005; Zhu et
al., 2005; Zhang et al., 2009). It has become increasingly
acknowledged that NK cells are pivotal in maternal adaption
to pregnancy as they are the largest population of immune
cells during the first trimester in human deciduas and show
a close reaction to invasive fetal trophoblasts and stromal
cells (Colucci and Kieckbusch, 2015; Tao et al., 2015). EVT
cells from the fetus express the following unique array of
MHC class Ι molecules: HLA-C, HLA-E, and HLA-G but
not HLA-A or HLA-B (Apps et al., 2009). Decidual NK
cells express receptors for these HLA class I molecules from
the trophoblast and, thus, are able to mediate allorecognition
of the fetus. With excessive inhibition of decidual NK cells,
the risk of growth restriction and pre-eclampsia is increased
(Sharkey et al., 2015). The present review summarizes the
concepts and rationale for the remodeled immune system
during pregnancy. We further review the formation and
education of decidual NK cells and interactions between
maternal NK cells and fetal growth.
THE FORMATION PROCESS OF THE
MATERNAL-FETAL IMMUNE INTERFACE
AND BASIC CHARACTERISTICS
Formation of the maternal-fetal immune interface
The invasion of trophoblastic cells is the starting factor of
maternal-fetal interface formation. The trophoblastic cells
derived from the embryo blastocyst layer position in the em-
bryo’s most outer layer and the layer of the uterus. During the
process of human embryonic development, trophoblasts dif-
ferentiate into two types, namely, villous trophoblasts (VTs)
and extravillous trophoblast cells (EVTs) (Arck and Hecher,
2013; Parham and Moffett, 2013). VTs form chorionic villi,
which are over the surface of the villi and have the ability to
transport nutrients and oxygen to the fetus; EVTs stretch into
decidual tissues, invade blood vessel linings, and reconstruct
the spiral artery. Trophoblast cells have many features that
are easily ignored by immune scholars. The invasion of tro-
phoblastic cells in the embryo and maternal interface depends
on the expression of maternal and paternal genes, including
MHC andMHC-like molecules, allowing mutual recognition
towards decidual NK cells, T lymphocytes and DCs.
Decidualization is one of the main features of the forming
maternal-fetal interface. The characteristic of decidualiza-
tion is mainly for the proliferation and differentiation of
endometrial stromal cells (ESCs) into large round cells with
abundant cytoplasm with nuclear and phenotypic changes
of decidual stromal cells. Decidua originating in the spiral
artery, with the growth of the embryo and the invasion of
the trophoblastic cells, spread step-by-step to the whole
endometrium (Maruyama and Yoshimura, 2008; Ramathal
et al., 2010). When the embryo’s implantation is completed,
the endometrium is called the decidua. In humans and mice,
the progress of decidualization is consistent with that of
trophoblastic cell invasion. Moreover, trophoblastic cell
invasion further plays a regulatory role in blastocyst implan-
tation, placenta formation and the maintenance of normal
pregnancy. Endometrial decidualization is one of the essen-
tial conditions for successful embryo growth. Insufficiency
in decidualization may cause infertility, repetitive abortion
(recurrent or repetitive spontaneous abortion, RSA), fetal
developmental delay (intrauterine growth retardation, IUGR)
and other diseases.
The modified immune environment at the maternal-fetal
immune interface
Decidual immune cells are the key factors in maintaining the
maternal-fetal interface. During the period of endometrial
decidualization, maternal peripheral immune cells accumu-
late locally, proliferate and further become decidual immune
cells. In early pregnancy, decidual immune cells can reach
30%–40% of the total number of cells in the uterus, includ-
ing NK cells, DCs, macrophages and T cells. B cells can
hardly be measured. Specifically, decidual NK cells, as the
main type of immune cells in deciduas, increase significantly
and constitute approximately 70% of the local total number
of immune cells.
The maternal-fetal interface is a special immune microen-
vironment that is mainly composed of fetal trophoblast cells,
maternal decidual stromal cells, decidual glandular epithelial
cells and immune cells. This maternal-fetal interface supplies
enough nutrition for the embryo, and it also provides immune
protection for the embryo, which is the key to protecting the
embryo frommaternal immune attack. In the process of preg-
nancy, there are two unique immune interfaces (Sargent et
al., 2006); the first interface is composed of the immune cells
in the decidua (dNK, T, Mo, and DCs), invasive trophoblas-
tic cells from fetal villi, a large number of decidual stromal
cells and the spiral artery. The second interface is composed
of immune cells from the maternal circulation system (in-
cluding DC, T, Mo, NK) and placental chorion surface syn-
cytial trophoblast cells. The formation of the first interface
and the second interface occurs in continuous phases. The
first interface mainly appears in the early weeks of pregnancy
and degenerates in the third trimester with the invasion of
trophoblastic cells and the associated decidual lymphocytes.
The second interface starts to appear at eight to nine weeks
of gestation with the formation of uteroplacental circulation,
and it gradually becomes the main maternal-fetal interface
with the growth of the placenta until the end of pregnancy.
The immune microenvironment formed by the maternal-fetal
immune interface, and the mechanisms for avoiding mater-
nal-fetal conflict and maintaining maternal-fetal immune tol-
erance, have special evolutionary wisdom by nature.
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IMMUNE CELL SUBSETS AND THEIR
DYNAMIC CHANGES IN THE MATERNAL-
FETAL INTERFACE
During early embryonic development, blastocyst adhesion
and endometrial implantation is accompanied by endometrial
cells forming decidual stromal cells (DSCs) as promoted by
estrogen and progesterone (Matson and Caron, 2014). In the
microenvironment created by DSCs, blastocysts differenti-
ated into functionally unique villous trophoblast cells (EVTs).
These EVTs in early pregnancy period not only express the
unique HLA, but they also co-express chemokine receptors
(CXCRs) and the corresponding chemokines (CXCLs) to-
gether with DSCs. This complex chemokine-chemokine re-
ceptor expression system, not only attracts EVT invasion of
the deciduas, but it also attracts many immune cells into the
deciduas. The number of immune cells can reach as high as
30%–40% of the total number of decidual cells at 9–12 weeks
of pregnancy (Du et al., 2014).
NK cells
NK cells are the most important decidual immune cells,
accounting for 50%–70% of the total number of immune
cells after 9–12 weeks of pregnancy. The decidual NK
cell and peripheral blood NK cell (pbNK) show distinct
phenotypes (Fu et al., 2011). Fully 90%–95% of NK cells
in peripheral blood are CD56dimCD16+ NK cells (Li et al.,
2015), whereas most decidual NK cells are CD56brightCD16−
NK cells. Further analysis found that CD56brightCD16− NK
cells express CXCR4, and they can be selectively recruited
into the decidua by interaction with chemokine CXCL12
secreted by DSCs and EVTs. CXCL9 and CXCL10 secreted
by DSCs can further interact with CXCR3 expressed on
CD56brightCD16− NK cells and allow decidual NK cells to
stay local (Hanna et al., 2003; Wu et al., 2005). There are still
debates about the source of decidual NK cells. On the one
side, IL-15 and stem cell factor (SCF) secreted from DSCs
prompt Lin−CD45+CD34+ decidual hematopoietic stem cells
(dHSCs) to develop into dNK cells (Vacca et al., 2011); on
the other side, DSCs and ETVs may also produce TGFβ
and IL-15 to transform CD56dimCD16+ NK cells into dNKs
in the deciduas environment (Keskin et al., 2007), thereby
maintaining the high content of decidual NK cells.
Macrophages
Macrophages are the second largest category of immune cells
in decidual tissue, accounting for approximately 20% of all
the immune cells. During the period of embryo implanta-
tion, the human decidual stromal cells, decidual NK cells
and glandular epithelial cells possess the ability to produce
CSF1, which, on the one hand, promotes the proliferation
and differentiation of macrophages; on the other hand, it in-
duces macrophages to express the monocyte chemokine fac-
tors CCL2 (MCP-1), CCL7 (MCP-3) and CCL12 (MCP-5).
These chemokines continue to attract circulating monocytes
into the decidua, where they differentiate into macrophages
and expand the amount of macrophages (Repnik et al., 2008;
Houser et al., 2011).
Decidual macrophages in early pregnancy can be divided
into two groups. One is called CD209+ macrophages,
referring to macrophages expressing molecular CD209
c-type lectin (DC-SIGN), which account for 70% of de-
cidual macrophages. These cells have a high expression
of CD163, CD206 (MRC-1, mannose receptor), CD304
(NRP-1, neuropilin 1) and ICAM-3 but a low expression
of CD11c and may act as identifiers of pathogenic mi-
croorganisms and immune response effectors. CD209+
macrophages are responsive towards infection in the decidua
and chorionic inflammation. The CD209 molecule is also
one of the typical signs of immature DCs derived from
mononuclear cells. Whether CD209 molecules have other
functions such as induction of immune tolerance is yet to be
confirmed. CD209− macrophages have the phenotypes of
CD163−CD206−CD304−ICAM3−CD11chi, expressing higher
levels of IL-10 at the basic level or from stimulation with
LPS than CD209+ macrophages. This feature results in
CD209− macrophages that tend to be the M2 type. Specifi-
cally, both CD209+ macrophages and CD209− macrophages
can be induced into M1 or M2 type in vitro. With the ini-
tiation of parturition or preterm delivery, a large number of
decidual macrophages again gather locally in the deciduas,
accompanied by decreased secretion of IL-10 but increased
secretion of inflammatory cytokines, further suggesting
that inflammation may play a role in starting the delivery
(Hamilton et al., 2012; Gomez-Lopez et al., 2014). All of
these phenomena indicate that decidual macrophage cells
are a type of special group that performs a special function,
being involved in organizational recasting, renovation of
apoptotic cells, inducing a locally tolerant microenvironment
during early pregnancy and starting the delivery in late
pregnancy (Erlebacher, 2013a). Decidual macrophages in
mice are divided into the F4/80+MHCIIhi and F4/80+MHCIIlo
subgroups, expressing CD163 and Mrc1, respectively, and
they are equivalent to the human decidual CD209+ and
CD209− macrophage subgroups (Tagliani et al., 2011).
DCs
There are few DCs in the decidua. Approximately 1–5
mm−2 mature CD83+mDCs distribute in the decidua during
early pregnancy. CD205+DCs are even fewer, only 2 mm−2,
which is obviously fewer than the number of macrophages
in the decidua in early pregnancy, approximately 50–100
mm−2. CD83+mDCs also exist in the endometrium, at ap-
proximately 3 mm−2 in the physiological breeding period and
reaching 9 mm−2 in secretory phase, which suggests that the
decidualization after embryo implantation limits the increase
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in the number of DCs (Kemp et al., 2011). The same phe-
nomenon also occurs in mice. Deciduas in mice are mainly
Ly6C−F4/80−MHCII+CD11c+DCs (Collins et al., 2009).
A reduced number of DCs suggests that DC cells have dif-
ficulty capturing enough antigens in the specific decidual mi-
croenvironment and presenting these antigens to T cells in the
lymph nodes through the lymph vessels. Moreover, decidual
DCs also lack the capacity of migrating to lymph nodes. The
density of lymphatic vessel in decidua is low, only scattered
around the spiral arteries, suggesting that the small amount of
DCs in decidua can contact the villous trophoblastic cells but
do not have a homing ability to the lymph nodes in the womb.
This limited contact may retain the immune response ability
when uterine mucosa are infected by pathogens and initiate
the Th2 state in the uterine microenvironment (Leno-Durán et
al., 2014). Additionally, decidual CD209+ macrophages can
highly express CD83 and stimulate T cell proliferation after
treatment with IL–1β, IL-6, TNFα and PEG2, potentially act-
ing as DC precursor cells when necessary.
T cells
CD3+T cells account for 10%–20%of decidual immune cells.
Among them, 30%–45% of T cells are CD4+ T cells, approx-
imately 50% of which have the activation/memory CD25dim
phenotype. Of T cells, 45%–75% are CD8+, 40% of which
show the effect/memory CD28− phenotype. Among these
CD4+ T cells, CD25bright Foxp3+ regulatory T cells, TH2 cells
and TH17 cells account for 5%, 5% and 2%, respectively.
TH1 cells account for 5%–30% of CD4+ T cells. γδT cells,
CD4−CD8−TCRαβ T cells, and NKT cells are rare in deciduas
(Tilburgs et al., 2010).
The physiological functions of T cells in decidual tissues
are almost unknown. Mice with T cell defects are not af-
fected in their reproductive capacity. There is no nourish-
ing function similar to that of dNKs or macrophages. Exces-
sive TH17 cell presence in spontaneous abortion cases is even
considered to have a negative impact on pregnancy (Fu et al.,
2014). However, the role of Treg in embryonic tolerance is
still unclear (Erlebacher, 2013b). Decidual Treg cells were
identified as CD4+CD25+FoxP3+Cigs1+Nrp1low, distinguish-
ing from Nrp1+Treg cells in the thymus (Arck and Hecher,
2013). Currently, it is difficult to identify whether there are
embryo/placenta antigen-specific T cells performing TCR-
mediated effects or regulatory functions. The effect of T cells
appearing in pregnancy related diseases is unlikely generated
locally, but a product of the immune response of the whole
body. This type of T cell effect lacks embryonic/placenta
specificity, and it can also be the result of excessive activa-
tion of cytokines.
From the foregoing, decidual immune cells form a unique
microenvironment, have a dynamic development process in
pregnancy, peak in the recasting spiral artery phase, and even
reach 30%–40% of all local cells in early pregnancy decidual
tissues. Decidual immune cells are characterized by natural
immune cells in the majority (NK cells and macrophages in
absolute dominance) and maintain an immune tolerance as a
result. For immune scientists, however, there are still many
difficult questions as follows: how can a new immune mi-
croenvironment be formed in endometrial tissue and decidual
tissue, in which the lymphatic vessels are lacking in both hu-
mans and mice and which cannot participate in lymphocyte
recirculation? Why do very unique immune cells appear in
decidual tissue, especially a large number of CD56brightCD16−
NK cells and CD209+ macrophages? Why do T cells, B cells
and DCs, which are important in the immune system of the
whole body, decrease significantly in decidual tissue? How is
the immune tolerance of the maternal-fetal interface is main-
tained?
SPECIAL NK SUBSETS IN THE MATERNAL-
FETAL INTERFACE
The phenotype of decidual NK cells
pbNK cells have a CD56dimCD16+ phenotype and are en-
dowed with ADCC function (Ni et al., 2013; Li et al., 2015;
Wang et al., 2015). pbNK cells also express CD11a and
CD11b, forming LFA-1 and MAC-1, respectively, with
CD18, which all have ICAM-1 as their corresponding lig-
and. ICAM-1 combined with LFA-1 is the key molecule
promoting pbNK cell adhesion with target cells and particle
polarization.
In contrast with pbNK cells, decidual NK cells show the
CD56brightCD16− phenotype and express CD49a highly but
not CD11b (pbNK cells are CD49a−) (Montaldo et al., 2016).
The CD49a ligands are collagen and laminin, which are ex-
pressed very highly in decidual tissue and may be one of the
reasons for the decidual residence of NK cells. Our previ-
ous laboratory work found that CD49a+NK cells accounted
for half of all hepatic NK cells (Peng et al., 2013), potentially
mediating immune tolerance in the liver. Interestingly, the
liver is considered an immune tolerance organ. Transplanta-
tion of the liver does not require HLA matching. This liver
tolerance condition is similar to that of the maternal-fetal in-
terface, which suggests that decidual NK cells are a special
immune cell type with the potential to mediate immune tol-
erance.
The education of decidual NK cells
The formation of NK cell function requires them to accept
the education of their MHCmolecules. NK cells express sev-
eral inhibitory and activating molecules. Before their educa-
tion, receptors of NK cells intertwine, limiting the function of
NK cells. After education from MHC molecules, the molec-
ular activation is limited within a specific domain, whereas
inhibitory receptors are limited by a grid structure mediated
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by actin; therefore, the NK cells are able to identify the cor-
responding cells dependent on the presence of MHC ligands
and accept the activation signal (Guia et al., 2011).
Decidual NK cells also need education. Maternal educa-
tion from MHC molecules should follow the rules above.
The core problem is how maternal NK cells are educated by
semi-allogeneic embryonic cells in the formation of tolerance
to the semi-allogeneic fetus. Whether NK cells can be tol-
erant with self-antigens and kill non-self cells is dependent
on the combination ability of their inhibitory receptors with
HLA class I molecules. The key subject in education is the
MHCmolecules. Extravillous trophoblast cells at the first in-
terface do not express HLA-A or HLA-B antigens that will
induce rejection responses from T cells, but they do express
very unique HLA-C, HLA-E and HLA-G (Sharkey et al.,
2015). Therefore, HLAmolecules expressed on trophoblastic
cells become the key molecules in the education of decidual
NK cells. Among these HLA molecules, HLA-C is only ex-
pressed in trophoblastic cells. The corresponding receptors
of HLA-C are killer cell immunoglobulin receptor molecules
(KIRs), which are also important receptors on the surface of
NK cells. Thus, the recognition and education of KIRs from
HLA-C is particularly important. KIRs combine with differ-
ent types of MHC class I molecules, such as KIR2DL1 com-
bined with HLA-C2, KIR2DL3 combined with HLA-C1, and
KIR3DL1 combined with HLA-Bw4. HLA-E can combine
with another type of inhibitory receptor onNK cells, NKG2A,
which limits the killing activity of NK cells. HLA-G has a
function similar to that of HLA-E. Further study found that
HLA-G can also induce tolerance of DCs and induce NK cells
to secrete cytokines and angiogenesis factors, thus showing
polyfunctionality (LeMaoult et al., 2004; van der Meer et al.,
2004; Li et al., 2009; Rajagopalan, 2014). At the surface of
the second interface, the syncytial trophoblast cells do not ex-
press MHC molecules; therefore, they cannot induce an anti-
gen specific response from maternal T cells (Moffett-King,
2002). An education function of syncytial trophoblasts to-
wards NK cells has not been confirmed.
NKG2A and KIRs mediate tolerance in two ways. One is
by inhibiting the function of NK cells after combining with
HLAmolecules on the surface of normal cells; the other is by
regulating NK cell function after accepting education from
HLA molecules on the surface of normal cells. NK cells that
do not express inhibitory receptors will lose the education
effect of MHC I molecules, showing low reactivity towards
MHC-I− target cells (Ivarsson et al., 2013).
The function of decidual NK cells
Decidual NK cells are necessary for promoting embryonic
development and maintaining the tolerance of decidual NK
cells towards embryonic cells. Decidual NK cells consti-
tute as much as 70% of lymphocytes in early pregnancy and
are supposed to have special physiological functions. Anne
Croy’s group first found that in tgε26 mice (deficient in NK
cells), many abnormalities appear in uterine glands, decidua
and blood vessels, and embryo abortion will occur with up to
64% probability in the middle of pregnancy. In this model,
adoptive transfer of bone marrow from SCID mice (T and
B cell defects) can reverse this pregnancy disorder phenom-
enon, thereby proving that decidual NK cells play an im-
portant role in the promotion of deciduas development and
blood vessel formation (Guimond et al., 1998). Afterward,
researchers found that decidual NK cells regulate the invasion
of trophoblastic cells and blood vessel recasting by the se-
cretion of angiogenesis regulation molecules, cytokines and
chemokines (Hanna et al., 2006; Lima et al., 2014). A series
of soluble molecules, including GM-CSF, can be produced
after coculturing KIR2DS1+dNK cells with HLA-C2+ target
cells in vitro, which can significantly enhance the capacity
of trophoblast cell invasion (Xiong et al., 2013). Decidual
NK cells can also inhibit inflammatory T helper type 17 cells
(Fu et al., 2013), promote regulatory T cells and the genera-
tion of indoleamine 2,3-dioxygenase (IDO)-producingmono-
cytes, induce the apoptosis of effector T cells (Vacca et al.,
2010) and participate in the formation of early mouse decidua
basalis (Felker and Croy, 2016). These findings provide im-
portant evidence that decidual NK cells act as sentinel cells to
control local inflammation and tolerance during pregnancy.
The frequency of KIR expression is significantly increased
in decidual NK cells in early pregnancy compared with pe-
ripheral blood NK cells (pbNK), and these KIRs combine
easily with HLA-C molecules (Male et al., 2011). Analysis
of the different responses of NK cells after KIRs form differ-
ent individual combinations with HLA-C is very important
to understanding the role of NK cells in the maternal-fetal
interface. Maternal dNK cells, for example KIR AA haplo-
type, when combined with HLA-C1 from maternal self and
HLA-C2 from paternal genetic nourishing cells results in the
inhibition of NK cells, increasing the risk of preeclampsia
(Parham and Moffett, 2013) because the mother is carrying
KIR2DL1 inhibitory receptors in such cases but lacks acti-
vated receptor KIR2DS1. When KIR2DL1 from the mother
combines with HLA-C2 from the embryo, dNK cells are sup-
pressed, cannot release cytokines or have direct contact with
EVTs, and do not provide enough support for EVT invasion
of vascular vessels. The combination between KIR A haplo-
type gene KIR2DL1 and HLA-C2 mediates strong inhibitory
signals that can cause defects in placenta formation. Thus, the
combination ability of KIR/HLA-C will influence the capa-
bility of dNK cells to secrete chemokines and cytokines and
will further have an impact on the important ability to reg-
ulate the invasion of trophoblastic cells (Hanna et al., 2006;
Hiby et al., 2010). KIR2DL2 and KIR2DS2, also belonging
to KIR B haplotype, can reduce the expression frequency of
KIRAhaplotypeKIR2DL1 and increase the activation ability
of NK cells because KIR2DS2 itself is an activated receptor
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and can be antagonized by KIR2DL1. Although KIR2DL2
and KIR2DL1 are both inhibitory receptors and can com-
bine with HLA-C2, the binding force and inhibition effect of
KIR2DL2 is weaker. KIR2DL2 expression has priority over
KIR2DL1 during the growth phase of NK cells. Reducing the
expression level of KIR2DL1 can also improve the ability of
NK cell activation and recasting of blood vessels, reducing
the risk of pre-eclampsia. However, mothers with KIR hap-
loid type 2DS1, if they carry an HLA-C2 embryo at the same
time, can experience overweight fetus and obstructed labor
(Hiby et al., 2010; Hiby et al., 2014).
Previous evidence suggests that the normal physiologi-
cal function of dNK cells guarantees a normal pregnancy,
whereas decreased function of dNK cells leads to pregnancy
failure. It is still unknown how dNK cells disorder naturally,
but it is essential for maintaining the appropriate activation
state of NK cells in each normal pregnancy. Therefore,
inhibition of NK cells in clinical treatment function may
lead to greater risk (Beaman et al., 2014). Some clinical
testing found that the number and activity of peripheral blood
NK cells have “relevance” to adverse pregnancy; there-
fore, patients have been given glucocorticoid, intravenous
immunoglobulin and anti-TNF-α antibody for treatment
(Moffett and Shreeve, 2015). This way of treatment appar-
ently lacks enough support. The phenotype, activity, and
even appearance are highly distinct between peripheral blood
pbNKs and decidual NK cells. Using test results from pbNKs
to characterize the dNK state will mislead our judgment. The
present data show that dNK cells need moderate activation
rather than suppression. The rush of using drugs targeting
dNKs before clearly distinguishing the function of dNK cells
is unsuitable and should be stopped (Moffett and Colucci,
2014).
CONCLUSION
Decidual NK cells and their interaction with semi-allogeneic
trophoblast cells may not only have an important effect on fe-
tal growth by negotiating the suitable allocation of nutrients
from the mother, but they also have an impact on the health of
offspring later in adult life (Colucci and Kieckbusch, 2015).
One example is that those individuals who are at a lower
weight when they are born have fewer glomeruli (Hughson
et al., 2003) and may be predisposed to renal disease during
adulthood (Hoy et al., 1998; Hoy et al., 1999; Yudkin et al.,
2001). Such damage and shortages in body development dur-
ing the sensitive time point during pregnancy are irreversible.
The discovery that NK cells mediate the regulation of fetal
growth and immune tolerance suggests that we should han-
dle clinical drug administration in a delicate matter if these
drugs could affect or suppress the activation or function of
NK cells.
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